BCI Pharma

About:

BCI Pharma is a biopharmaceutical company that designs and synthesizes kinase inhibitor libraries.

Top Investors: TCD Capital (ex TheClubDeal)

Description:

BCI Pharma designs and synthesizes kinase inhibitor libraries. They identify novel, potent, and selective kinase inhibitor hits. They develop cell-based assays. They also plan to deliver medications for inflammatory diseases, CNS disorders, and cancer. Their goal is to create a world-renowned firm that its patients, customers, investors, business partners, and the communities where they work and live regard highly.

Total Funding Amount:

3.9M EUR

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Grabels, Languedoc-Roussillon, France

Founded Date:

2013-01-01

Founders:

Dominique Surleraux, Elisabeth Picou

Number of Employees:

1-10

Last Funding Date:

2018-03-12

IPO Status:

Private

Industries: